Nike has teamed up with Good360 to donate 32,500 pairs of its Air Zoom Pulse shoes, specifically designed for healthcare workers, across the U.S. and in parts of Europe.

Jorge Casimiro, Nike's chief social and community impact officer, told Cheddar Monday that Nike athletes are leading the effort to show their appreciation for frontline workers taking on the coronavirus pandemic.  

"Together, with these great Nike athletes what we want to do is show that appreciation by donating our most innovative footwear for the healthcare athlete, the Air Zoom Pulse," Casimiro said.

Along with the sneakers, the sportswear giant is also donating over 140,000 pieces of footwear, apparel, and equipment globally. Casimiro also said they are reaching out to local communities to find out the needs of those on the front line so they can provide them with the right gear.  

"We have teams on the ground. These are cities that are important for our employees, for our consumers, where we have deep relationships, and we listen to their needs," he said 

Nike also committed more than $25 million in products and funding to COVID-19 response efforts, including $2 million in employee donations. The company says it has invested in providing personal protective equipment (PPE) for healthcare workers, and Casimiro said the company intends to continue to listen to medical professionals on the frontlines to fill their needs.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More